The Beijing Evening News channel visited Beijing Continent Pharmaceuticals for its pirfenidone product development program and interviewed Dr. Ying Luo.

F351 clinical trial for liver fibrosis

The China Pharmaceutical & Biotechnology Review, a monthly publication covering all aspects of the industry (2012 volume 58), published a panel discussion with Dr. Ying Luo and other Experts from biotechs and research institutes in China.

Research Findings of F573 Published

The NIKKEI SANGYO SHINBUN, newspaper of Japan published an article describing the progress of F351 development in China.